Urination Disorders D014555

Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Urination Disorders

Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Urination Disorders

Description

Abnormalities in the process of URINE voiding, including bladder control, frequency of URINATION, as well as the volume and composition of URINE.   MeSH

Hierarchy View

Subtype Terms (9)

Anuria
 

Enuresis
7 approved drugs

Glycosuria
 

Hematuria
13 drugs (11 approved, 2 experimental)

Oliguria
3 approved drugs

Polyuria
4 drugs (2 approved, 2 experimental)

Proteinuria
77 drugs (63 approved, 14 experimental)

Urinary Incontinence
48 drugs (23 approved, 25 experimental)

Urinary Retention
13 drugs (12 approved, 1 experimental)



Organization Involved with Phase 4 Indications (3)

Organization Involved with Phase 3 Indications (1)

Organization Involved with Phase 2 Indications (3)

Organization Involved with Phase 1 Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.